Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Objectives. Many patients with bipolar disorder suffer from metabolic disorder. Lovastatin is effective for treating major depression. This double-blind randomized placebo controlled clinical trial investigates whether lovastatin is a useful adjuvant to lithium for treating mania. Methods. Fifty-fou...
Main Authors: | Ahmad Ghanizadeh, Motahhar OmraniSigaroodi, Ali Javadpour, Mohammad Hossein Dabbaghmanesh, Sara Shafiee |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Depression Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2014/730505 |
Similar Items
-
Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China
by: Liu Y, et al.
Published: (2020-11-01) -
Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng)
by: Remzi Oğulcan Çıray, et al.
Published: (2020-06-01) -
Verbal processing in patients with bipolar disorder during a manic episode
by: Garyfallos George, et al.
Published: (2008-04-01) -
Bipolar disorder and adherence: implications of manic subjective experience on treatment disruption
by: Bulteau S, et al.
Published: (2018-07-01) -
QT and P-wave dispersion during the manic phase of bipolar disorder
by: Gurok MG, et al.
Published: (2019-07-01)